Analysts Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $2.25

Cardlytics, Inc. (NASDAQ:CDLX) has been given a consensus rating of “Reduce” by the five ratings firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $1.75.

A number of equities analysts have recently commented on CDLX shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Evercore set a $1.00 price objective on Cardlytics in a report on Friday, March 6th. Finally, Bank of America restated an “underperform” rating on shares of Cardlytics in a research note on Thursday, March 5th.

Insider Activity

In other news, CEO Amit Gupta sold 45,159 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $0.93, for a total value of $41,997.87. Following the sale, the chief executive officer directly owned 659,644 shares of the company’s stock, valued at approximately $613,468.92. This represents a 6.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders have sold 117,875 shares of company stock valued at $113,022 over the last quarter. Corporate insiders own 4.40% of the company’s stock.

Hedge Funds Weigh In On Cardlytics

Several hedge funds have recently bought and sold shares of CDLX. Bank of America Corp DE increased its holdings in Cardlytics by 262.7% during the 3rd quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock worth $3,968,000 after acquiring an additional 1,182,593 shares during the period. Quinn Opportunity Partners LLC boosted its holdings in Cardlytics by 900.0% in the 3rd quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock valued at $2,673,000 after purchasing an additional 990,000 shares during the period. Geode Capital Management LLC grew its position in shares of Cardlytics by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after purchasing an additional 20,908 shares in the last quarter. Citizens Financial Group Inc. RI purchased a new position in shares of Cardlytics during the 3rd quarter valued at $1,260,000. Finally, UBS Group AG increased its holdings in shares of Cardlytics by 112.5% in the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares during the period. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Cardlytics Stock Performance

NASDAQ CDLX opened at $0.70 on Thursday. The firm has a market cap of $38.70 million, a P/E ratio of -0.36 and a beta of 1.03. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 2.87. The company’s 50 day moving average is $1.02 and its 200-day moving average is $1.36. Cardlytics has a 12-month low of $0.66 and a 12-month high of $3.28.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.08). Cardlytics had a negative return on equity of 370.98% and a negative net margin of 44.36%.The business had revenue of $56.10 million during the quarter, compared to the consensus estimate of $54.46 million. Sell-side analysts predict that Cardlytics will post -1.52 earnings per share for the current year.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.